Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI
NCT ID: NCT03911895
Last Updated: 2019-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1 participants
OBSERVATIONAL
2019-07-01
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
NCT04110691
PITT PCI Xience Registry
NCT01299207
Optimal Stent Deployment Strategy of Contemporary Stents
NCT05292651
Critical Treatment of Coronary Artery Disease
NCT03195621
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with coronary artery diseas undergoing PCI
Effect of stent length on patients with coronary artery undergoing PCI
Stent more than 26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)
Stent equal to or less than26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stent more than 26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)
Stent equal to or less than26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Abd elbaset Hassan
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed abdelbast
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Stent length impact on PCI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.